A renewed appreciation for ocular immune privilege.
Niederkorn
Jerry Y
JY
D000818:Animals; D003167:Complement Activation; D051056:Complement Inactivating Agents / Q000494:pharmacology; D003165:Complement System Proteins / Q000276:immunology*; D004195:Disease Models, Animal; D004546:Elapid Venoms; D005123:Eye / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D008268:Macular Degeneration / Q000209:etiology / Q000235:genetics / Q000276:immunology*; D011110:Polymorphism, Genetic; D011817:Rabbits; D051381:Rats; D014606:Uveitis, Anterior / Q000276:immunology
D051056:Complement Inactivating Agents; D004546:Elapid Venoms; C016310:cobra venom factor; D003165:Complement System Proteins